NEA leads Series B round for Loxo Oncology

... as chief scientific officer. Loxo Oncology is a a biopharmaceutical company focused on targeted cancer therapies. STAMFORD, Conn., May 06, 2014 (BUSINESS WIRE) - Loxo Oncology, Inc., a biopharmaceutical company focused on developing targeted cancer ...

http://ift.tt/1mCcnAp